Clinicopathological Characteristics and Prognostic Factors of Diffuse Infiltrating Glioma in Morocco: A Retrospective Single-Center Institutional Experience Under the 2021 WHO Classification
Authors:
- Oumaima BouchraOBOumaima Bouchra
- Chaymae El BahaCBChaymae El Baha
- Sara El GuendouziSGSara El Guendouzi
- Amina EssalihiAEAmina Essalihi
- Zineb KhadroufZKZineb Khadrouf
- Khadija KhadiriKKKhadija Khadiri
- Souha SahraouiSSSouha Sahraoui
- Reda Ben MridRMReda Ben Mrid
- Najat BouchmaaNBNajat Bouchmaa
- Rachid El FatimyRFRachid El Fatimy
- Mehdi KarkouriMehdi Karkouri
Open Access
- 2 August 2026
- journal article
- Published by Elsevier in World Neurosurgery
- Vol. 213
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Gender differences in gliomas: From epidemiological trends to changes at the hormonal and molecular levelsCancer Letters, 2024
- Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guidelineNeuro-Oncology, 2023
- The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1—Key Points of the Fifth Edition and Summary of Imaging Findings on Adult‐Type Diffuse GliomasJournal of Magnetic Resonance Imaging, 2023
- Adult-type and Pediatric-type Diffuse GliomasClinical Neuroradiology, 2023
- New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival predictionInternational Journal of Cancer, 2022
- Radiotherapy for glioblastoma patients with poor performance statusJournal of Cancer Research and Clinical Oncology, 2021
- Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomasNeuro-Oncology, 2021
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology, 2021
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014JAMA Oncology, 2018
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005